CD34 and myelodysplastic syndrome: These microarray data were confirmed by QRT-PCR analysis of MYBL2 expression levels in 10 MDS cases and eight normal CD34+ bone marrow samples, including four additional normal control CD34+ samples that were not part of the original microarray analysis (Figure 1B).